GSK Aventis Searle Ferozsons Analysis on Financial Statements of Pharmaceutical Companies in Pakistan
Introduction to Pharmaceutical Industry <ul><li>Pakistan meets 80% of its domestic demand of medicines from local producti...
<ul><li>GSK facts  </li></ul><ul><li>GSK dedicated to R&D for 80 years  </li></ul><ul><li>Cost of bringing a medicine to m...
Horizontal Analysis
 
 
 
 
 
 
 
VERTICAL ANALYSIS
 
 
 
CASH FLOWS
 
 
 
 
RATIOS
 
 
 
 
 
 
 
 
Users of Financial Statements <ul><li>Investors Point of view </li></ul><ul><li>Creditors point of view </li></ul><ul><li>...
Other Factors <ul><li>Company Reputation </li></ul><ul><li>Contribution to Society </li></ul><ul><li>Stakeholder engagemen...
Upcoming SlideShare
Loading in...5
×

Analysis On Financial Statement Of Pharmaceutical Co. In Pakistan

6,661

Published on

Analysis on the financial Statemnet of GSK, Aventis, Searle and Ferozsons.

2 Comments
8 Likes
Statistics
Notes
No Downloads
Views
Total Views
6,661
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
2
Likes
8
Embeds 0
No embeds

No notes for slide

Analysis On Financial Statement Of Pharmaceutical Co. In Pakistan

  1. 1. GSK Aventis Searle Ferozsons Analysis on Financial Statements of Pharmaceutical Companies in Pakistan
  2. 2. Introduction to Pharmaceutical Industry <ul><li>Pakistan meets 80% of its domestic demand of medicines from local production and 20% through imports. </li></ul><ul><li>The pharmaceuticals market size is Rs. 70 Billion (US $ 1.2 Billion), approximately. </li></ul><ul><li>Introduction to GSK </li></ul><ul><li>GlaxoSmithKline Pakistan Limited was created on January 1st 2002 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Wellcome (Pakistan) Limited- standing today as the largest pharmaceutical company in Pakistan </li></ul>
  3. 3. <ul><li>GSK facts </li></ul><ul><li>GSK dedicated to R&D for 80 years </li></ul><ul><li>Cost of bringing a medicine to market: $800 million (Rs 4.8 billion) </li></ul><ul><li>Average length of time to discover new drug: 10-15 years </li></ul><ul><li>5 out of every 10,000 compounds investigated reach clinical trial phase and only 1 of those gets approved for patient use. </li></ul><ul><li>GSK has industry's most extensive portfolio of R&D projects for diseases affecting developing countries </li></ul>
  4. 4. Horizontal Analysis
  5. 12. VERTICAL ANALYSIS
  6. 16. CASH FLOWS
  7. 21. RATIOS
  8. 30. Users of Financial Statements <ul><li>Investors Point of view </li></ul><ul><li>Creditors point of view </li></ul><ul><li>Employees point of view </li></ul><ul><li>Government point of view </li></ul>
  9. 31. Other Factors <ul><li>Company Reputation </li></ul><ul><li>Contribution to Society </li></ul><ul><li>Stakeholder engagement </li></ul>

×